Amid high AQI in Delhi, there's been a surge in the demand for respiratory drugs. Foracort, a respiratory drug, has emerged ...

Incyte (Nasdaq: INCY) today announced that the Company will present new data from across its oncology portfolio at the 2024 American Society of Hematology (ASH) Annual Meeting in San Diego. “These ...

Bob Baffert is back in business at Churchill Downs after a three-year plus suspension by the track owners. Barnes, a $3.2 ...

If you want an anti-itch remedy for your dog that's free from chemicals and won't break the bank, look no further than your ...

Using single maintenance and reliever therapy (SMART) is cost‐effective vs ICS/LABA maintenance plus SABA reliever in uncontrolled asthma.

A new study shows that COVID-19 infection significantly increases the risk of exacerbation in patients with myasthenia gravis (MG).

Dapirolizumab pegol was better than a placebo at controlling disease activity in systemic lupus erythematosus patients in a Phase 3 trial.

Both LUNA and OPTIC were designed to assess a broad wet AMD population, including hard-to-treat patients with severe disease ...

LUNA is an ongoing double-masked, randomized Phase 2 trial. OPTIC is an ongoing, open-label, dose-ranging first-in-human ...

MoonLake Immunotherapeutics' shares have dipped recently, with a catalyst vacuum until mid-2025 when pivotal trial data for ...

For the first time since the spring of 2021, when he began serving what was ultimately more than a three-year suspension by ...

Tapering doses of corticosteroids was safer than, and just as effective as, a fixed dose in patients with severe ...